INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE

This adverse event was reported 642 times

These drugs are most commonly taken by patients reporting INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE:

# Drug Count
0 FUROSEMIDE 92
1 ALLOPURINOL 86
2 ASPIRIN 83
3 ASPIRIN 325 MG 83
4 ASPIRIN 81 MG 83
5 OMEPRAZOLE MAGNESIUM 79
6 OMEPRAZOLE 78
7 ALBUTEROL SULFATE 74
8 PANTOPRAZOLE 72
9 PREDNISOLONE 70
See all common drugs associated with INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE

INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AGING CHEST AND NECK RESCUE TREATMENT CREAM 1 0.0112
1 IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS 1 0.0109
2 METEX 2 0.0053
3 SORBITOL 3 0.0050
4 NIZATIDINE 7 0.0046
5 AMINOPHYLLINE 7 0.0035
6 SODIUM MONOFLUOROPHOSPHATE 1 0.0027
7 AMOXICILLIN AND CLAVULANATE POTASSIUM 11 0.0024
8 CICLESONIDE 30 0.0022
9 FOSNETUPITANT AND PALONOSETRON 2 0.0017
See all drugs enriched for association with INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE

INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 3 0.0044
1 Vasopressin Receptor Agonist [EPC] 1 0.0030
2 CD38-directed Cytolytic Antibody [EPC] 10 0.0017
3 Cardiac Glycoside [EPC] 46 0.0006
4 Aluminum Complex [EPC] 15 0.0006
5 Endoglycosidase [EPC] 1 0.0005
6 Xanthine Oxidase Inhibitor [EPC] 86 0.0005
7 P2Y12 Platelet Inhibitor [EPC] 56 0.0005
8 Antihypoglycemic Agent [EPC] 2 0.0005
9 beta Lactamase Inhibitor [EPC] 2 0.0004
See all drug classes enriched for association with INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE